Report Categories
View AllRecent Articles
View All
OVID Ovid Therapeutics swings to profit with 1181 revenue jump defying biotech sector headwinds in Q4 2025
MTR Mesa shares retreat slightly after reporting Q4 EPS of 004 amid energy sector headwinds
IVR INVESCO climbs 246 percent on positive investor sentiment despite Q1 2026 EPS narrowly missing analyst estimates
How ServiceNow NOW is positioning for the next five years Volatility Increases 20260506